Immunogen appoints Sayare to CEO
NEW YORK Biotech company Immunogen has appointed a new CEO.
The company announced that Mitchell Sayare would leave the company, and Daniel Junius would replace him.
Immunogen focuses on antibody-based cancer biologics and works with companies such as Biogen Idec, Bayer Health Care and Sanofi-Aventis.